Cargando…

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?

This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stienen, J. J. C., Ottevanger, P. B., Wennekes, L., van de Schans, S. A. M., Dekker, H. M., van der Maazen, R. W. M., van Krieken, J. H. J. M., Blijlevens, N. M. A., Hermens, R. P. M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432098/ https://www.ncbi.nlm.nih.gov/pubmed/25772630 http://dx.doi.org/10.1007/s00277-015-2340-0

Ejemplares similares

Variation in guideline adherence in non-Hodgkin’s lymphoma care: impact of patient and hospital characteristics
por: Stienen, Jozette J.C., et al.
Publicado: (2015)

Improvement of hospital care for patients with non-Hodgkin’s lymphoma: protocol for a cluster randomized controlled trial (PEARL study)
por: Stienen, Jozette JC, et al.
Publicado: (2013)

Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway
por: Stienen, Jozette JC, et al.
Publicado: (2015)

PCR clonality detection in Hodgkin lymphoma
por: Hebeda, K. M., et al.
Publicado: (2009)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2022)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma
por: Strobbe, L., et al.
Publicado: (2016)

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2023)

Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

A case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting with spontaneous splenic rupture: an extremely unusual presentation
por: Hebeda, K. M., et al.
Publicado: (2000)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Improved survival time trends in Hodgkin's lymphoma
por: Koshy, Matthew, et al.
Publicado: (2016)

New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008
por: van Krieken, J. Han J. M.
Publicado: (2008)

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma
por: Drechsel, K. C. E., et al.
Publicado: (2023)

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015)

New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017
por: van Krieken, J. H.
Publicado: (2017)

New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017
por: van Krieken, J. H.
Publicado: (2017)

DNA content and prognosis of non-Hodgkin's lymphoma.
por: Morgan, D. R., et al.
Publicado: (1986)

Healthcare professionals’ perspectives of barriers and facilitators in implementing physical activity programmes delivered to cancer survivors in a shared-care model: a qualitative study
por: IJsbrandy, Charlotte, et al.
Publicado: (2019)

Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: a cross-sectional observational study
por: IJsbrandy, Charlotte, et al.
Publicado: (2020)

Evaluation of two strategies to implement physical cancer rehabilitation guidelines for survivors of abdominopelvic cavity tumors: a controlled before-and-after study
por: IJsbrandy, Charlotte, et al.
Publicado: (2021)

Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial
por: Overbeek, L. I., et al.
Publicado: (2010)

Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients
por: van Eijndhoven, Monique A.J., et al.
Publicado: (2016)

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)

Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis and DNA repair
por: Ding, Y, et al.
Publicado: (2012)

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.
por: Brada, M., et al.
Publicado: (1987)

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.
por: Woll, P. J., et al.
Publicado: (1995)

Some aspects of the etiology of non-Hodgkin's lymphoma.
por: Hardell, L, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_m25e5vji4159vtgou21t2u48cr